Perbak Capital Partners LLP Twist Bioscience Corp Transaction History
Perbak Capital Partners LLP
- $568 Billion
- Q3 2025
A detailed history of Perbak Capital Partners LLP transactions in Twist Bioscience Corp stock. As of the latest transaction made, Perbak Capital Partners LLP holds 46,415 shares of TWST stock, worth $1.25 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
46,415
Previous 23,610
96.59%
Holding current value
$1.25 Million
Previous $869 Million
50.37%
% of portfolio
0.23%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding TWST
# of Institutions
263Shares Held
74.4MCall Options Held
150KPut Options Held
81.1K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.73MShares$181 Million1.33% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.41MShares$172 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.77MShares$155 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$146 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL4.14MShares$111 Million0.33% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $1.51B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...